Singapore Institute of Advanced Medicine Holdings Ltd. (SG:9G2) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The Singapore Institute of Advanced Medicine Holdings Ltd. has announced that its subsidiary, Proton Therapy Pte. Ltd., has entered into a three-year agreement with Icon SOC Pte. Ltd. to provide proton therapy treatment services to cancer patients, commencing on 1 July 2024. This partnership signifies a collaborative effort to enhance oncology services by integrating advanced proton therapy into Icon’s comprehensive cancer treatment offerings. The financial terms of the agreement involve a fee schedule for services rendered, with provisions for renewal and termination.
For further insights into SG:9G2 stock, check out TipRanks’ Stock Analysis page.